NO742601L - - Google Patents

Info

Publication number
NO742601L
NO742601L NO742601A NO742601A NO742601L NO 742601 L NO742601 L NO 742601L NO 742601 A NO742601 A NO 742601A NO 742601 A NO742601 A NO 742601A NO 742601 L NO742601 L NO 742601L
Authority
NO
Norway
Prior art keywords
carboxylic acid
carbazole
methyl
chloro
ethyl ester
Prior art date
Application number
NO742601A
Other languages
English (en)
Norwegian (no)
Inventor
H Biere
H Ahrens
C Rufer
E Schroeder
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2337154A external-priority patent/DE2337154C2/de
Priority claimed from DE2431292A external-priority patent/DE2431292A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO742601L publication Critical patent/NO742601L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO742601A 1973-07-18 1974-07-17 NO742601L (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2337154A DE2337154C2 (de) 1973-07-18 1973-07-18 Neue Carbazolderivate
DE2431292A DE2431292A1 (de) 1974-06-27 1974-06-27 Neue carbazol-derivate

Publications (1)

Publication Number Publication Date
NO742601L true NO742601L (es) 1975-02-17

Family

ID=25765532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO742601A NO742601L (es) 1973-07-18 1974-07-17

Country Status (20)

Country Link
JP (1) JPS5069072A (es)
AT (1) AT342583B (es)
BG (1) BG25793A3 (es)
CA (1) CA1053682A (es)
CH (1) CH619213A5 (es)
CS (1) CS190431B2 (es)
DD (1) DD114075A5 (es)
DK (1) DK388074A (es)
ES (1) ES428379A1 (es)
FI (1) FI218874A (es)
FR (1) FR2237628B1 (es)
GB (1) GB1482771A (es)
HU (1) HU173115B (es)
IE (1) IE39624B1 (es)
IL (1) IL45298A (es)
NL (1) NL7409715A (es)
NO (1) NO742601L (es)
RO (1) RO72713A (es)
SE (1) SE396602B (es)
SU (1) SU511855A3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
JP4908215B2 (ja) * 2003-09-12 2012-04-04 エリクサー ファーマスーティカルズ インコーポレイテッド 疾患の治療法
US8143257B2 (en) * 2004-11-23 2012-03-27 Ptc Therapeutics, Inc. Substituted phenols as active agents inhibiting VEGF production
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CA3059631A1 (en) * 2017-04-11 2018-10-18 Saje Pharma, Llc Carbazole compounds and methods of use thereof
JP2021134141A (ja) * 2020-02-21 2021-09-13 エヌ・イーケムキャット株式会社 不均一系貴金属触媒を用いた芳香族化合物の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7008628A (es) * 1969-06-25 1970-12-29

Also Published As

Publication number Publication date
BG25793A3 (en) 1978-12-12
ES428379A1 (es) 1976-09-16
DD114075A5 (es) 1975-07-12
GB1482771A (en) 1977-08-17
IL45298A (en) 1980-01-31
CH619213A5 (en) 1980-09-15
IE39624B1 (en) 1978-11-22
FI218874A (es) 1975-01-19
IE39624L (en) 1975-01-18
ATA596074A (de) 1977-08-15
SE7409330L (es) 1975-01-20
JPS5069072A (es) 1975-06-09
NL7409715A (nl) 1975-01-21
CA1053682A (en) 1979-05-01
FR2237628A1 (es) 1975-02-14
SE396602B (sv) 1977-09-26
DK388074A (es) 1975-03-03
CS190431B2 (en) 1979-05-31
RO72713A (ro) 1982-09-09
SU511855A3 (ru) 1976-04-25
HU173115B (hu) 1979-02-28
FR2237628B1 (es) 1977-05-20
AT342583B (de) 1978-04-10
IL45298A0 (en) 1974-10-22

Similar Documents

Publication Publication Date Title
US3896145A (en) Carbazoles
FI64357B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ftalazin-4-ylaettiksyraderivat
FI66368C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 6,1-dihydro-11-oxodibens(b e)oxepin-2-aettiksyraderivat
NO145139B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav
KR960010350B1 (ko) 사이클릭 안트라닐산 유도체 및 이의 제조방법
NO177934B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kinolinkarboksylsyrederivater
NO142865B (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO742601L (es)
DK149230B (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
US3956295A (en) Carbazole derivatives
US3320268A (en) 1-aroyl or heteroaroyl-7-azaindole-3-carboxylates and derivatives
CS226021B2 (en) Method of presparing piperidine propylderivatives
IL46783A (en) Aromatic dicarboximides their manufacture and pharmaceutical preparations containing them
US4057640A (en) 5,6,7,8:Tetrahydrocarbazole-1-carboxylic acid derivatives
US3763218A (en) Esters of phenylalanine
NO158185B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,5-difenylpyrazolin-3-on-forbindelser.
NO179513B (no) 2-substituerte kinolylmetoksy-fenyleddiksyrederivater, legemidler inneholdende dem samt deres anvendelse for fremstilling av legemidler
US4151170A (en) Process for the manufacture of indigoid dyes
NO141757B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(2-(beta-naftyloksy)-etyl)-3-metyl-pyrazolon-(5) og dets salter
JP2733490B2 (ja) 置換1,3,4,9‐テトラヒドロピラノ[3,4‐b]インドール‐1‐酢酸
KR20000029545A (ko) Cox-2에대한피라노인돌및카바졸억제제
US4116966A (en) 1-Benzoxepino[4,3-c]pyridines
JPS5995257A (ja) インド−ル誘導体、その製法及び該化合物を含有する抗癌作用を有する医薬組成物
EP0435993A1 (en) Process for the preparation of methyl-quinoline derivatives
US3649634A (en) 4-alkoxy-2 3-dihydro-1h-pyrrolo(2.3-b)quinoline compounds